Literature DB >> 21390411

Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study.

J K Burns1, K Jhazbhay, R Emsley.   

Abstract

OBJECTIVE: Cannabis use/abuse is a common co-morbid problem in patients experiencing a first episode of psychotic illness (FEP). The relationship between the clinical presentation of FEP and cannabis abuse is complex and warrants further investigation, especially within the South African context.
METHOD: We tested associations between recent/current cannabis use and duration of untreated psychosis (DUP), age of onset (AO), PANSS-rated (Positive and Negative Syndrome Scale) positive, negative and general psychopathology symptoms and depressive symptoms (Calgary Depression Scale for Schizophrenia) in a sample of 54 patients with FEP.
RESULTS: Mean DUP was 34.4 weeks, while mean AO was 24.7 years. Co-morbid cannabis use occurred in 35% of the sample and was significantly associated with shorter DUP (Mann-Whitney U, p=0.026). While not significant, there was also a trend association between cannabis use and lower negative symptoms (Mann-Whitney U, p=0.051).
CONCLUSION: Current/recent cannabis use was associated with clinical features of psychosis onset that previously have been associated with better outcome. Medium and long-term outcome for cannabis users however, is likely to depend on whether or not cannabis use is ongoing.

Entities:  

Mesh:

Year:  2010        PMID: 21390411     DOI: 10.4314/ajpsy.v13i5.63106

Source DB:  PubMed          Journal:  Afr J Psychiatry (Johannesbg)


  6 in total

1.  Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients.

Authors:  Inge Gorynia; Markus Schwaiger; Andreas Heinz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-05-04       Impact factor: 5.270

2.  Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa.

Authors:  Glen P Davis; Andrew Tomita; Joy Noel Baumgartner; Sisanda Mtshemla; Siphumelele Nene; Howard King; Ezra Susser; Jonathan K Burns
Journal:  S Afr J Psychiatr       Date:  2016-05-20       Impact factor: 1.550

3.  Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population.

Authors:  Anum Muzaffar; Sami Ullah; Fazal Subhan; Zahid Nazar; Syed Mehdi Hussain; Fazli Khuda; Abuzar Khan; Ameer Khusro; Muhammad Umar Khayam Sahibzada; Sarah Albogami; Ahmed M El-Shehawi; Talha Bin Emran; Binish Javed; Javed Ali
Journal:  Front Psychiatry       Date:  2021-12-03       Impact factor: 4.157

4.  Premorbid adjustment amongst outpatients with schizophrenia in a Nigerian psychiatric facility.

Authors:  Omokehinde O Fakorede; Adegboyega Ogunwale; Akinwande O Akinhanmi
Journal:  S Afr J Psychiatr       Date:  2021-05-28       Impact factor: 1.550

Review 5.  Pathways from cannabis to psychosis: a review of the evidence.

Authors:  Jonathan K Burns
Journal:  Front Psychiatry       Date:  2013-10-14       Impact factor: 4.157

6.  Factors that influence delaying initial psychiatric treatment in rural Cambodia: A pilot study.

Authors:  Akihiro Nishio; Ryo Horita; Toshiyuki Marutani; Mayumi Yamamoto
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.